News genOway

Equities

ALGEN

FR0004053510

Real-time Euronext Paris Other stock markets 09:49:45 2024-04-24 am EDT			5-day change	1st Jan Change
3.96 ^EUR	+0.51%		+0.51%	-13.91%

2023	GenOway: sharp rise, broker initiates buy recommendation	CF
2023	GENOWAY : Euroland initiates buy coverage	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GenOway : Résultats annuels 2023	Mar. 27	PU
GenOway: sharp rise, broker initiates buy recommendation	Nov. 22	CF
GENOWAY : Euroland initiates buy coverage	Nov. 22	CF
GenOway : Résultats du 1er semestre 2023	23-09-22	PU
GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI
Global markets live: Exxon Mobil, Apple, KKR, Amazon, Tesla...	23-04-11
GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-19	CI
Sigma-Aldrich and genOway Expand Their CRISPR/CAS9 Strategic Alliance	22-09-08	CI
GenOway: Proposal of a new administrator	22-05-23	PU
GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
GenOway grants the leading UK academic research funder a non-exclusive license for CRISPR/Cas9 technology	22-01-25	PR
GenOway Grants the Leading UK Academic Research Funder A Non-Exclusive License for CRISPR/Cas9 Technology	22-01-25	CI
Global markets live: Michelin, Facebook, UBS, Tesla, Volvo...	21-10-26
Genoway Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-27	CI
GenOway Société anonyme announced that it has received €5.6 million in funding from NextStage AM	21-05-26	CI
GenOway Société anonyme announced that it expects to receive €5 million in funding from NextStage AM	21-05-05	CI
Genoway Soci?T? Anonyme Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
Genoway S.A. Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-17	CI
GenOway S.A. announced that it has received €1.7 million in funding from Eximium SAS, Dassault Développement and other investors	20-01-27	CI
GenOway : and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models	20-01-07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News genOway

Equities

ALGEN

FR0004053510

Summary

Filters